| Hi, Agen. In the first half of 2024, U.S. seed funding was flat compared to H2 2023 and down from H1 2023, but what does that mean for startups reaching for that elusive Series A? Using Crunchbase data, we tracked seed rounds and provide a look at some of the dilemmas founders face taking that next step. Plus, the women’s health sector minted a brand-new unicorn with Flo Health’s $200 million Series C. As companies spend a longer time at seed — raising multiple seed rounds in this climate of larger fundings — fewer are graduating to Series A. This begs the question: At which point will these companies be able to progress? London-based Flo Health, a provider of a popular women’s health app, raised more than $200 million in a Series C round at a unicorn valuation. The financing is one of a number of large rounds in recent quarters for women’s health startups. Related Crunchbase Pro list: Women’s Health Startups That Raised Larger Rounds In The Past 2 Years From personalized supplements to better sleep to saving the Earth through more effective insulation, July saw a lot of cool startups raising cash. Two years into a venture funding slowdown, a lift from mega-rounds and AI funding signaled a stronger quarter in Q2. And there are signs that active venture investors, who backed off from the peak volume of 2021, are picking up the pace a little. However, despite some good signals the overall outlook from the venture markets has not shifted. With few exceptions, indoor farming has not done especially well in raising venture capital lately. But that hasn’t stopped South San Francisco-based Plenty who has been busy planting seeds in a joint venture to build a network of indoor farms in the Middle East. Related Crunchbase Pro list: Indoor- And Vertical-Farming-Related Funded Companies | 
WATCH A DEMO
No comments:
Post a Comment